全文获取类型
收费全文 | 276153篇 |
免费 | 58741篇 |
国内免费 | 13569篇 |
专业分类
耳鼻咽喉 | 3295篇 |
儿科学 | 6211篇 |
妇产科学 | 3144篇 |
基础医学 | 38820篇 |
口腔科学 | 8565篇 |
临床医学 | 38650篇 |
内科学 | 51514篇 |
皮肤病学 | 9520篇 |
神经病学 | 23099篇 |
特种医学 | 9200篇 |
外国民族医学 | 117篇 |
外科学 | 33610篇 |
综合类 | 34035篇 |
现状与发展 | 44篇 |
一般理论 | 49篇 |
预防医学 | 17825篇 |
眼科学 | 6445篇 |
药学 | 27206篇 |
201篇 | |
中国医学 | 13177篇 |
肿瘤学 | 23736篇 |
出版年
2024年 | 801篇 |
2023年 | 3327篇 |
2022年 | 8674篇 |
2021年 | 12019篇 |
2020年 | 12932篇 |
2019年 | 17218篇 |
2018年 | 16953篇 |
2017年 | 17703篇 |
2016年 | 17921篇 |
2015年 | 21057篇 |
2014年 | 23074篇 |
2013年 | 22547篇 |
2012年 | 19596篇 |
2011年 | 20915篇 |
2010年 | 19475篇 |
2009年 | 13425篇 |
2008年 | 12970篇 |
2007年 | 11465篇 |
2006年 | 11076篇 |
2005年 | 10621篇 |
2004年 | 7106篇 |
2003年 | 6588篇 |
2002年 | 5650篇 |
2001年 | 4987篇 |
2000年 | 5021篇 |
1999年 | 4669篇 |
1998年 | 2695篇 |
1997年 | 2750篇 |
1996年 | 2061篇 |
1995年 | 2029篇 |
1994年 | 1739篇 |
1993年 | 1058篇 |
1992年 | 1445篇 |
1991年 | 1243篇 |
1990年 | 1020篇 |
1989年 | 926篇 |
1988年 | 856篇 |
1987年 | 689篇 |
1986年 | 523篇 |
1985年 | 440篇 |
1984年 | 209篇 |
1983年 | 176篇 |
1982年 | 103篇 |
1981年 | 135篇 |
1980年 | 85篇 |
1979年 | 116篇 |
1978年 | 53篇 |
1977年 | 51篇 |
1976年 | 42篇 |
1974年 | 44篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
21.
22.
胰岛素使用方法的研究进展 总被引:11,自引:0,他引:11
胰岛素治疗是糖尿病治疗的重要内容,也是使糖尿病患者血糖达标的有效方法。严格的血糖控制对糖尿病慢性并发症的预防和延缓发生有重要意义,然而目前各国的糖尿病血糖控制达标率均不足50%。患者甚至包括医生对低血糖的恐惧是启动胰岛素治疗和达到最佳胰岛素治疗的主要障碍之一。 相似文献
23.
人胚雪旺细胞组织工程神经修复坐骨神经缺损的实验研究 总被引:1,自引:0,他引:1
目的:探索人胚雪旺细胞作为组织工程的种子细胞修复周围神经缺损的可行性。方法:通过组织工程方法用PLGA导管和polyglactin 910纤维负载人胚雪旺细胞预先构置好人工神经,然后用于修复大鼠20mm的坐骨神经缺损,并与神经切断后原位缝合以及用单纯的PLGA导管进行修复的实验组进行对照。通过活体肢体功能观察、靶器官肌肉测量、电生理检测、辣根过氧化物酶示踪、连续组织切片图像分析以及透射电镜等检查神经再生情况。结果:人工神经修复组神经再生良好,效果接近于神经原位缝合组,明显优于单纯的PLGA导管修复组。结论:人胚雪旺细胞构建的人工神经可以修复20mm的周围神经缺损。 相似文献
24.
尽早发现故障苗头,并将故障消灭于萌芽状态,是预防性维修的目的,是维修工作的最高境界,具体工作包括定期保养,定期检查,随即处置隐患,根据从业多年经验小结了一些针对螺旋CT的预防性维修感受。 相似文献
25.
26.
27.
We report clinical, neuroradiologic features, and neuropathologic findings of a 76‐year‐old man with coexistent Pick’s disease and progressive supranuclear palsy. The patient presented with loss of recent memory, abnormal behavior and change in personality at the age of 60. The symptoms were progressive. Three years later, repetitive or compulsive behavior became prominent. About 9 years after onset, he had difficulty moving and became bed‐ridden because of a fracture of his left leg. His condition gradually deteriorated and he developed mutism and became vegetative. The patient died from pneumonia 16 years after the onset of symptoms. Serial MRI scans showed progressive cortex atrophy, especially in the bilateral frontal and temporal lobes. Macroscopic inspection showed severe atrophy of the whole brain, including cerebrum, brainstem and cerebellum. Microscopic observations showed extensive superficial spongiosis and severe neuronal loss with gliosis in the second and third cortical layers in the frontal, temporal and parietal cortex. There were Pick cells and argyrophilic Pick bodies, which were tau‐ and ubiquitin‐positive in neurons of layers II–III of the above‐mentioned cortex. Numerous argyrophilic Pick bodies were observed in the hippocampus, especially in the dentate fascia. In addition, moderate to severe loss of neurons was found with gliosis and a lot of Gallyas/tau‐positive globus neurofibrillary tangles in the caudate nucleus, globus pallidus, thalamus, substantia nigra, locus coeruleus and dentate nucleus. Numerous thorned‐astrocytes and coiled bodies but no‐tuft shaped astrocytes were noted in the basal ganglion, brainstem and cerebellar white matter. In conclusion, these histopathological features were compatible with classical Pick’s disease and coexistence with progressive supranuclear palsy without tuft‐shaped astrocytes. 相似文献
28.
A. Nakao H. Toyokawa A. Tsung M. A. Nalesnik D. B. Stolz J. Kohmoto A. Ikeda K. Tomiyama T. Harada T. Takahashi R. Yang M. P. Fink K. Morita A. M. K. Choi N. Murase 《American journal of transplantation》2006,6(10):2243-2255
Carbon monoxide (CO), a byproduct of heme catalysis, was shown to have potent cytoprotective and anti-inflammatory effects. In vivo recipient CO inhalation at low concentrations prevented ischemia/reperfusion (I/R) injury associated with small intestinal transplantation (SITx). This study examined whether ex vivo delivery of CO in University of Wisconsin (UW) solution could ameliorate intestinal I/R injury. Orthotopic syngenic SITx was performed in Lewis rats after 6 h cold preservation in control UW or UW that was bubbled with CO gas (0.1-5%) (CO-UW). Recipient survival with intestinal grafts preserved in 5%, but not 0.1%, CO-UW improved to 86.7% (13/15) from 53% (9/17) with control UW. At 3 h after SITx, grafts stored in 5% CO-UW showed improved intestinal barrier function, less mucosal denudation and reduced inflammatory mediator upregulation compared to those in control UW. Preservation in CO-UW associated with reduced vascular resistance (end preservation), increased graft cyclic guanosine monophosphate levels (1 h), and improved graft blood flow (1 h). Protective effects of CO-UW were reversed by ODQ, an inhibitor of soluble guanylyl cyclase. In vitro culture experiment also showed better preservation of vascular endothelial cells with CO-UW. The study suggests that ex vivo CO delivery into UW solution would be a simple and innovative therapeutic strategy to prevent transplant-induced I/R injury. 相似文献
29.
C. M. Crceles J. M. Serrano P. Marín E. Escudero E. Fernndez‐Varn 《Transboundary and Emerging Diseases》2006,53(6):300-304
The pharmacokinetics (PK) of moxifloxacin in healthy white New Zealand rabbits was studied following intravenous (IV) and subcutaneous (SC) administration routes as well as a SC long‐acting poloxamer 407 gel formulation (SC‐P407). Moxifloxacin concentrations were determined by high‐performance liquid chromatography assay with fluorescence detection. Mean half‐life for IV, SC and SC‐P407 routes was 2.15, 5.41 and 11.09 h. Clearance value after IV dosing was 0.78 l/kg/h. After SC administration, the mean absolute bioavailability was 117% and the Cmax was 1.61 ± 0.49 mg/l. After SC‐P407 administration, the bioavailability was 44% and the Cmax 1.83 was ±0.62 mg/l. No adverse effects were observed in any of the rabbits following IV, SC and SC‐P407 administration of moxifloxacin. Minimal inhibitory concentrations of moxifloxacin against different strains of Staphylococcus aureus from different european countries were used to compute the main pharmacodynamic (PD) surrogate markers of efficacy. The high tolerability of this SC‐P407 formulation and the favourable PK behaviour such as the long half‐life, acceptable bioavailability and excellent PK–PD ratios achieved indicate that it is likely to be effective in rabbits. 相似文献
30.
目的 探讨癫(癎)患者先兆症状的发生比例、临床表现,为正确诊断治疗癫(癎)提供依据.方法 回顾性研究1028例癫(癎)患者的临床资料,分析癫(癎)患者的先兆发生率、临床表现、脑电图和神经影像学结果.比较伴或不伴先兆的部分性发作癫(癎)患者的发病年龄、性别、脑电图、神经影像学的差异以及腹部先兆在颞叶内外侧癫(癎)出现比例的差异.结果 部分性癫(癎)725例,484例(66.8 % )出现先兆;全面性发作者303例,无一例患者出现先兆.64例患者出现2种或2种以上的先兆表现;14例出现持续性先兆的癫(癎)患者.1028例患者中脑电图异常547例(53.2 % ),影像学异常217例(21.1 % ).484例有先兆症状的患者中286例脑电图异常(59.1 % ),126例(26.0 % )影像学异常.伴或不伴先兆的部分性发作癫(癎)患者的首次发病年龄差异无统计学意义,腹部先兆在颞叶内外侧癫(癎)出现的比例差异有统计学意义(x2=170.877,P<0.01).结论 癫(癎)患者先兆症状多样,分析先兆症状对于癫(癎)分型、病灶定位以及合理治疗有指导意义. 相似文献